MicroTech Medical, Inc. — a Chinese maker of medical equipment for the diagnosis and treatment of diabetes — has raised 575 million yuan ($88 million) in a funding round led by Beijing Taikang Investment Management, the investment arm of TaiKang Life’s subsidiary Taikang Asset Management.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in